Clinical Outcomes for Metastatic Renal Cell Carcinoma (mRCC) Patients Ineligible for Front-line Clinical Trials. Journal of Kidney Cancer, [S. l.], v. 11, n. 3, p. 51–58, 2024. DOI: 10.15586/jkcvhl.v11i3.352. Disponível em: https://jkcvhl.com/~jkcvhlco/index.php/jkcvhl/article/view/352. Acesso em: 17 apr. 2026.